Last reviewed · How we verify
NCT07439081: OPTIMUM
OPTIMUM Study of Remote Patient Monitoring in Ambulatory Heart Failure Care
trial testing Satelia® Cardio Remote Patient Monitoring System in Heart Failure in 504 participants. Completed in 1 July 2025.
1 July 2023
Quick facts
| Lead sponsor | Médipôle Lyon-Villeurbanne |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 504 |
| Start date | 1 January 2021 |
| Primary completion | 1 July 2023 |
| Estimated completion | 1 July 2025 |
| Sites | 1 location across France |
Drugs / interventions tested
- Satelia® Cardio Remote Patient Monitoring System
Conditions studied
- Heart Failure — all drugs for Heart Failure →
- Acute Heart Failure (AHF) — all drugs for Acute Heart Failure (AHF) →
Sponsor
Médipôle Lyon-Villeurbanne
Who can join
18 and older, any sex, with Heart Failure or Acute Heart Failure (AHF). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Heart failure is a leading cause of hospitalization and readmission, particularly among older adults with multiple comorbidities. Traditional outpatient follow-up may be insufficient to detect early clinical deterioration in this vulnerable population. Remote patient monitoring (RPM) using non-invasive symptom and weight tracking has been proposed to enhance ambulatory care, but its effectiveness appears to depend on integration within structured care pathways. The OPTIMUM study evaluated the real-world implementation of an integrated ambulatory heart failure care pathway combining non-invasive RPM with multidisciplinary follow-up in routine clinical practice. Patients enrolled after a recent heart failure hospitalization were managed using the Satelia® Cardio monitoring system, nurse-led therapeutic education, and a planned cardio-geriatric day-hospital reassessment. The study aimed to describe pathway implementation and assess associations with rehospitalizations, mortality, alert activity, and patient and healthcare professional satisfaction in an older, frail population.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07439081
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Heart Failure
Currently open trials in the same condition.
- NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
- NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
- NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
- NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
- NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
Other Médipôle Lyon-Villeurbanne trials
Trials by the same sponsor.
- NCT06600555 — Evaluation of the Metabolic Surgery Technique for Glycemic Improvement in Type 2 Diabetes · NA · recruiting
- NCT07041710 — Rehabilitation of Taste and Smell Disorders Associated With Chemotherapy Using Aromatherapy · NA · recruiting
- NCT07018687 — Improvement of Nutritional Status in Cancer Patients and Reduction of Malnutrition · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07439081 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Médipôle Lyon-Villeurbanne
- Last refreshed: 27 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07439081.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing